Viewing StudyNCT01134250



Ignite Creation Date: 2024-05-05 @ 10:35 PM
Last Modification Date: 2024-10-26 @ 10:20 AM
Study NCT ID: NCT01134250
Status: COMPLETED
Last Update Posted: 2022-04-15
First Post: 2010-05-25

Brief Title: Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients
Sponsor: Philogen SpA
Organization: Philogen SpA

Conditions & Keywords Data

Conditions:
Name
Non-small Cell Lung Cancer NSCLC
Solid Tumor
Breast Cancer
Metastatic Melanoma
Keywords:
Name View
metastatic melanoma non-small cell lung cancer NSCLC View
Interleukin IL2 F16 monoclonal antibody cytokine Paclitaxel breast cancersolid tumour View